Sales decline 0.81% to Rs 119.02 crore
Net profit of Lincoln Pharmaceuticals declined 75.12% to Rs 1.00 crore in the quarter ended March 2017 as against Rs 4.02 crore during the previous quarter ended March 2016. Sales declined 0.81% to Rs 119.02 crore in the quarter ended March 2017 as against Rs 119.99 crore during the previous quarter ended March 2016.For the full year,net profit rose 14.27% to Rs 27.06 crore in the year ended March 2017 as against Rs 23.68 crore during the previous year ended March 2016. Sales declined 9.87% to Rs 360.64 crore in the year ended March 2017 as against Rs 400.15 crore during the previous year ended March 2016.
ParticularsQuarter EndedYear EndedMar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var.Sales119.02119.99 -1 360.64400.15 -10 OPM %3.672.51 -12.8910.13 - PBDT3.227.44 -57 42.3837.93 12 PBT1.816.15 -71 36.8433.07 11 NP1.004.02 -75 27.0623.68 14
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
